Table 7 Meta-analysis for the efficacy of colchicine on mortality among PCR confirmed COVID-19 Patients
From: The role of colchicine in the management of COVID-19: a Meta-analysis
Study | Type of study | Relative Risk | 95% CI | P-value |
|---|---|---|---|---|
Tardif et al. 2021 | RCT | 0.56 | 0.19–1.66 | 0.042 |
Recovery Collaborative Group 2021 | RCT | 1.02 | 0.94–1.10 | 0.70 |
Fixed Effect Model | 1.02 | 0.74–1.41 | – | |